Orthodontic treatments increase the incidence of white spot lesions. The objectives of this study were to develop an antibacterial orthodontic cement to inhibit demineralization, and to evaluate its enamel shear bond strength and anti-biofilm properties. Novel antibacterial monomer dimethylaminohexadecyl methacrylate (DMAHDM) was synthesized and incorporated into Transbond XT at 0, 1.5 and 3% by mass. Anti-biofilm activity was assessed using a human dental plaque microcosm biofilm model. Shear bond strength and adhesive remnant index were also tested. Biofilm activity precipitously dropped when contacting orthodontic cement with DMAHDM. Orthodontic cement containing 3% DMAHDM significantly reduced biofilm metabolic activity and lactic acid production (p<0.05), and decreased biofilm colony-forming unit (CFU) by two log. Water-aging for 90 days had no adverse influence on enamel shear bond strength (p>0.1). By incorporating DMAHDM into Transbond XT for the first time, the modified orthodontic cement obtained a strong antibacterial capability without compromising the enamel bond strength.
INTRODUCTION
Fixed orthodontic appliances tend to accumulate dental plaque biofilms adjacent to brackets and tubes, which complicates the patients' oral hygiene processes [1] [2] [3] . Greater accumulation of biofilms could increase the Streptococcus mutans (S. mutans) and Lactobacillus casei (L. casei), which are the two primary cariogenic pathogens related to decalcification and caries 4, 5) . S. mutans is cariogenic because it produces lactic acid and leads to local acidic pH 2) . Enamel surfaces around brackets and tubes can be dissolved by lactic acid, which leads to the development of white spot leisions [6] [7] [8] [9] . Furthermore, it could take only four weeks for white spot lesions to deteriorate into cavitated caries lesions 10) . Orthodontic patients usually spend 2.5 years wearing brackets, which is long enough to cause serious lesions. As a result, patients with fixed orthodontic appliances are vulnerable to white spot lesions and caries, especially those with poor oral hygiene 6) . Recent studies showed that 50-70% of patients had white spot lesions after fixed orthodontic treatment [11] [12] [13] . White spot lesions were considered as the main undesired adverse effect of fixed orthodontic treatment 6, 8, 11, 13, 14) . For orthodontists seeking effective preventive approaches, it is essential to be able to streamline the methods. Generally, it involves three aspects to prevent white spot lesions for patients with fixed orthodontic appliances: proper oral hygiene, dietary control, and fluoride therapy 6, 8, 15) . However, these approaches are unreliable because they rely on patient compliance 11, 13) . Therefore, other promising strategies, such as novel antibacterial orthodontic cements, need to be developed to prevent white spot lesions and caries.
Orthodontic cement plays an important role because it is in direct contact with both enamel surface and dental plaque biofilms. However, most currently available orthodontic cements lack antibacterial capability. To inhibit caries and obtain clinical benefits, several studies incorporated various antibacterial agents into dental resins, including chlorhexidine 16) , nanosilver 17) , 12-methacryloyloxydodecylpyridinium bromide (MDPB) 18, 19) , methacryloxylethyl cetyl dimethyl ammonium chloride (DMAE-CB) 20) , dimethylaminododecyl methacrylate (DMADDM) 10) and other antibacterial agents [21] [22] [23] . Quaternary ammonium monomers (QAMs) can cause bacteria lysis by disrupting the bacterial membranes and therefore effectively inhibit biofilm growth 24) . The methacrylate radical of QAMs can be immobilized in the resin matrix by copolymerizing with other dental monomers to endow a durable antibacterial property to dental adhesives and composites 23, 25) . Long-chained QAMs possess doublekilling effects including positive charges and physical insertion into the bacterial membrane 26, 27) .
Novel orthodontic cement containing dimethylaminohexadecyl methacrylate with strong antibacterial capability
Dimethylaminohexadecyl methacrylate (DMAHDM), with alkyl chain length (CL) of 16, was recently synthesized and showed the strongest antibacterial activity among a series of QAMs 27) . However, to date, no study has been reported with DMAHDM as the antibacterial agent in orthodontic adhesive systems.
The aims of this study were to develop a novel antibacterial orthodontic cement and to investigate the influence of adding DMAHDM on enamel bond strength and dental plaque microcosm biofilm properties for the first time. Two hypotheses were tested: (1) Strongly antibacterial orthodontic cement with DMAHDM could be developed without sacrificing the enamel bond strength; (2) DMAHDM-containing orthodontic adhesive would substantially reduce dental plaque microcosm biofilm growth, metabolic activity, and lactic acid production, compared to the commercial control orthodontic cement.
MATERIALS AND METHODS

Synthesis of DMAHDM
DMAHDM was synthesized using a modified Menschutkin reaction method in which a tertiary amine was reacted with an organo-halide 23, 28, 29) . The advantage of this method is that the reaction products are generated at virtually quantitative amounts and require no further purification 23) . To form DMAHDM, 10 mmol of 2-(dimethylamino) ethyl methacrylate (DMAEMA), 10 mmol of 1-bromohexadecane (BHD) (TCI America, Portland, OR, USA), and 3 g of ethanol were added and reacted in a 20 mL scintillation vial. DMAEMA provided the tertiary amine and ethanol was the solvent. The vial was capped and stirred at 70°C for 24 h for the reaction to complete 27) . After the ethanol was evaporated completely, DMAHDM was obtained as a viscous liquid. The reaction and products were verified via Fourier transform infrared spectroscopy in previous studies 28, 29) .
Fabrication of antibacterial orthodontic cement
Transbond XT (3M Unitek, Monrovia, CA, USA) was used as the parent system to develop a DMAHDMcontaining orthodontic cement with anti-biofilm properties. According to the manufacturer, Transbond XT consisted of silane-treated quartz (70-80% by weight), bisphenol-A-diglycidyl ether dimethacrylate (10-20%), bisphenol-A-bis (2-hydroxyethyl) dimethacrylate (5-10%), silane-treated silica (<2%) and diphenyliodonium hexafluorophosphate (<0.2%). DMAHDM was mixed with Transbond XT at DMAHDM/(DMAHDM+Transbond) mass fractions of 0, 1.5, and 3%. These mass fractions were selected on the basis of a previous study 10) . DMAHDM mass fractions>3% were not tested because of a decreased enamel bond strength 10) . For bacterial tests, disk specimens were fabricated using polyethylene molds (inner diameter=9 mm, thickness=2 mm). The orthodontic cement disks were photo-polymerized (Triad 2000, Dentsply, York, PA, USA) for 1 min on each open side, following a previous study 30) . The cured disks were immersed and agitated in sterile water for 1 h to remove any uncured monomers, then submitted to ethylene oxide sterilization (Anprolene AN 74i, Andersen, Haw River, NC, USA) 30) . Three groups were tested for enamel shear bond strength and anti-biofilm properties:
1. Transbond XT control with 0% DMAHDM (termed "TB control").
Enamel shear bond test and adhesive remnant index (ARI)
Ninety human maxillary first premolars without any caries or crackers were extracted and randomly allocated into three groups, with 30 teeth in each group. Each tooth was embedded vertically in a selfcuring acrylic resin (Lang Dental, Wheeling, IL, USA), and their labial surface were paralleled with the force direction during shear bond testing. Enamel was etched for 20 s (typically between 15-30 s according to the manufacturer's recommendation) with 37% phosphoric acid (Scotchbond, 3M ESPE, St. Paul, MN, USA) and then rinsed thoroughly with water for 10 s. The tooth was dried with a stream of oil-free compressed air. Transbond XT Primer was applied to the bonding surface and adhesive was placed to cover the bracket pad with a thin coat. Premolar metal orthodontic brackets (Ormco Series 2000, Sybron Dental, Orange, CA, USA) with a mean base surface area of 9.63 mm 2 were bonded to the teeth using each orthodontic adhesive group 31) . Flash was removed from all sides of the bracket with a micro brush. The adhesive was cured from mesial and distal sides for 10 s each, using a light-curing unit (Optilux VCL 401, Demetron Kerr, Danbury, CT, USA) 10) . The 30 bonded specimens of each group were divided into three subgroups of 10 specimens each, and were stored in distilled water at 37 °C for 15 min, 24 h, and 90 days, respectively, before the shear bond testing.
Shear bond strength was tested with a computercontrolled universal testing machine (MTS, Eden Prairie, MN, USA) using a chisel at a crosshead speed of 0.5 mm per min. The applied load was recorded until the bond failed. To prevent deformation of the bracket, a stainless steel wire (with cross-section of 0.019×0.025 inch) was ligated into each bracket slot during testing. The shear bond strength was calculated as the debonding force divided by the bracket surface area.
The residual adhesive on the tooth surface was examined and scored with a stereoscopic microscope (Leica Zoom 2000, Leica Microsystems, Wetzlar, Germany) using the ARI 3, 32) . The following scores were used: 0=no cement remaining on enamel; 1=less than half of the cement remaining on enamel; 2=more than half of cement remaining on enamel; 3=all the cement remaining on enamel, with a distinct impression of the bracket base.
Dental plaque microcosm biofilm model
Whole human saliva was used as an inoculum, in order to provide multi-species biofilms consisting of organisms found in the oral cavity. To maintain the diversity of bacterial populations, mixed saliva was collected from 10 healthy donors, who had natural dentitions without active caries or periodontitis, and did not take antibiotics within the last 3 months 33, 34) . The donor did not brush teeth for 24 h and abstained from food/drink intake for at least 2 h before donating saliva 28) . An equal volume from each of the subjects was pooled and mixed with sterile glycerol to a final 70% saliva concentration, and then stored at −80ºC for subsequent use 33, 34) . The use of human saliva microcosm model in this study was approved by Capital Medical University.
Live/dead biofilm staining
The saliva-glycerol stock was added, with 1:50 final dilution, to a growth medium as inoculum. The growth medium contained mucin (type II, porcine, gastric) at a concentration of 2.5 g/L; bacteriological peptone, 2.0 g/L; tryptone, 2.0 g/L; yeast extract, 1.0 g/L; NaCl, 0.35 g/L, KCl, 0.2 g/L; CaCl 2, 0.2 g/L; cysteine hydrochloride, 0.1 g/L; haemin, 0.001 g/L; vitamin K1, 0.0002 g/L, at pH 7 35) . Every disc sample was placed into a 24-well plate with 1.5 mL medium and incubated in 5% CO2 at 37ºC for 8 h. Each sample was transferred into a new 24-well plate with 1.5 mL fresh medium and then incubated for 16 h. Then, transfer each sample into a new 24-well plate with 1.5 mL fresh medium, and incubated for 24 h 36) . The 2-day biofilms on samples were gently rinsed with phosphate-buffered saline (PBS), live/dead stained with a bacterial viability kit (Molecular Probes, Eugene, OR, USA) and then examined with an epifluorescence microscope (TE2000-S, Nikon, Melville, NY, USA). Live bacteria were stained with Syto 9 to show a green fluorescence, and bacteria with damaged membranes were stained with propidium iodide to show a red fluorescence. Four representative images were taken for each sample, with three specimens yielding 12 images for each group 10) .
MTT assay of metabolic activity and lactic acid production Six separate cement disks were used for the MT assay for each group. Cement disks with 2-day biofilms were transferred to a new 24-well plate for the MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. The MTT is a colorimetric assay that measures the enzymatic reduction of MTT, a yellow tetrazole, into purple formazan 23, 37) . One milliliter of MTT dye (0.5 mg/mL MTT in PBS) was added to each well and incubated at 37°C in 5% CO 2 in the dark for 1 h. During this process, specific bacteria metabolized the yellow MTT and reduced it to purple formazan inside the living cells. After 1 h, the samples were transferred to a new 24-well plate, 1 mL of dimethyl sulfoxide (DMSO) was added to solubilize the formazan crystals, and the plate was incubated for 20 min with gentle mixing at room temperature in the dark 28) . After brief mixing via pipetting, 200 μL of the DMSO solution from each well was transferred to a 96-well plate, and the absorbance at 540 nm (OD540) was measured via the microplate reader (SpectraMax M5, Molecular Devices, Sunnyvale, CA, USA). A higher absorbance reflects a higher formazan concentration, which in turn reflects more metabolic activity in the biofilm on the surface of orthodontic cement 10) . Six separate cement disks were used for lactic acid production for each group. Cement disks inoculated and cultured for 2 days were rinsed with cysteine peptone water (CPW) to remove loosely-attached bacteria, and then transferred to 24-well plates containing 1.5 mL of buffered-peptone water (BPW) plus 0.2% sucrose. The samples were incubated for 3 h to allow the biofilms to produce acid. BPW solutions were stored and lactate concentrations were measured using an enzymatic method 36) . The 340 nm absorbance (OD340) of BPW was determined with a microplate reader (SpectraMax, Molecular Devices). Standard curves were prepared using a standard lactic acid (Supelco Analytical, Bellefonte, PA, USA).
Biofilm colony-forming unit (CFU) counts
Disks inoculated and cultured for 2 days were transferred into tubes with 2 mL CPW. Biofilm on each disk was harvested by sonication/vortexing (Fisher, Pittsburgh, PA, USA), according to a previous study 24) . Three types of agar plates were used to evaluate the microorganism viability after serially dilution in CPW. Tryptic soy agar (TSA) with sheep blood plates were aimed at determing total microorganisms 24, 28) . Mitis salivarius agar (MSA) culture plates containing 15% sucrose were used to determine total streptococci, since MSA inhibited many species of bacteria but streptococci 24, 28) . MSA agar plates with 0.2 units of bacitracin per mL were for determining the mutans streptococci, because bacitracin is a selective antibiotic which has no influence on cariogenic mutans streptococci 24, 28) .
Statistical analysis
One-way and two-way analyses-of-variance (ANOVA) were performed to detect the significant effects of the variables. Tukey's multiple comparison test was used to compare the data at p=0.05.
RESULTS
The enamel shear bond strengths of the orthodontic cements are plotted in Fig. 1 (mean±SD; n=10) . Control group at 15 min had the lowest shear bond strength, while the strengths of the other groups were not significantly different from each other (p>0.1). Therefore, incorporating DMAHDM up to 3% into orthodontic cement did not significantly decrease the bracket-enamel bond strength. In addition, there was no significant strength loss for all groups in water-aging from 1 day to 90 days (p>0.1). a ARI was examined according to the following scores: 0=no cement remaining on enamel; 1=less than half of the cement remaining on enamel; 2=more than half of cement remaining on enamel; 3=all the cement remaining on enamel, the failure site was between the cement and bracket base. Table 1 lists the ARI scores, indicating no significant differences among all the materials tested (p=0.77). The orthodontic adhesive containing up to 3% DMAHDM did not alter the bonding process, as failure occurred usually at the bracket-adhesive interface.
There was no significant difference between 15 min, 1 day and 30 days (p>0.1).
Representative live/dead staining images of the biofilms adherent on the orthodontic cements are shown in Fig. 2 : (A) Transbond XT control, (B) 1.5% DMAHDM, (C) 3% DMAHDM. Live bacteria were stained green, and bacteria with compromised membranes were stained red. Live and dead bacteria that were close to or on the top of each other produced yellow and orange colors. In (A), biofilms on control cement without DMAHDM had primarily live bacteria. In contrast, more compromised bacteria were observed in biofilms grown on the cement with 1.5% DMAHDM. Specimens containing 3% DMAHDM had mostly compromised bacteria. These results showed that increasing the mass fraction of DMAHDM in Transbond enhanced the antibacterial activity.
The microbiological results of biofilms adherent on the orthodontic cements are plotted in Fig. 3 : (A) metabolic activity from MTT assay, and (B) lactic acid production (mean±SD; n=6). In (A), the biofilms on the commercial orthodontic cement without DMAHDM had the highest metabolic activity. Incorporation of DMAHDM decreased the metabolic activity (p<0.05). Increasing the DMAHDM mass fraction to 3% resulted in a much lower metabolic activity, which was an order of magnitude lower than that of control (p<0.05). In (B), biofilms on control cement produced the most acid. Adding DMAHDM decreased the acid production (p<0.05). Incorporating DMAHDM at 3% further decreased the acid production of biofilms (p<0.05), which was only 10% that of control cement. Figure 4 plots the 2-day biofilm CFU counts on cements for: (A) Total microorganisms, (B) total streptococci, and (C) mutans streptococci (mean±SD; Fig. 2 Representative live/dead staining images of biofilms grown for 2 days on orthodontic cements. All images had the same magnification as (A). Live bacteria were stained green, and dead bacteria were stained red. Live and dead bacteria that were close to, or on the top of, each other produced yellow and orange colors. Control cement had primarily live bacteria, while the cement incorporating DMAHDM had mostly compromised bacteria. n=6). In each plot, the control cement had the highest CFU counts. All three CFU counts showed a similar decreasing trend with increasing DMAHDM mass fraction. Increasing the DMAHDM concentration to 3% enhanced the antibacterial activity by decreasing the CFU count by two orders of magnitude, compared to the commercial orthodontic cement (p<0.05).
DISCUSSION
The present study incorporated a novel antibacterial monomer DMAHDM into Transbond orthodontic cement for the first time. The modified orthodontic cement showed strong antibacterial capability with biofilm CFU two orders of magnitude lower than the commercial control cement. The enamel shear bond strength was not negatively affected by incorporating DMAHDM, and was successfully maintained after 3 months of water-aging, which demonstrated excellent bond strength durability for the DMAHDM-Transbond orthodontic cement for the first time. Despite persistent attempts, it is still unrealistic to fully remove the dental plaque around orthodontic brackets by brushing to prevent enamel demineralization. White spot lesions, as the most undesired side effect adverse effect of fixed orthodontic treatment, could be better controlled by changing the microenvironment around the bonded orthodontic beackets 38, 39) . Therefore, the development of antibacterial orthodontic cements could help inhibit biofilms and white spot lesions.
Dental resins containing QAMs have been synthesized with antibacterial properties. The positively-charged quaternary amine N + could insert into and damage the negatively-charged bacteria, resulting in membrane disruption and bacterial death 40) . Previous investigations demonstrated substantial decreases in biofilm growth, biofilm thickness and live-biofilm volume with increasing alkyl CL from 3 to 16 27, 41, 42) . The antibacterial efficacy weakened when CL was further increased to 18, possibly because the longer the alkyl chain, the easier it may block the positivelycharged quaternary ammonium groups and disturb the electrostatic interactions with the bacteria 41) . These results suggest that DMAHDM with alkyl chain of 16 may possess the strongest antibacterial capability. In the present study, orthodontic cement incorporating DMAHDM with potent antibacterial capability was developed, which greatly reduced biofilm metabolic activity, lactic acid production, and microcosm biofilm CFU.
To achieve clinically acceptable enamel bond strength, the modified orthodontic cement must provide at least 8 to 9 MPa of enamel bond strength to permit proper adhesion to brackets. In the present study, adding DMAHDM up to 3% into orthodontic cements did not significantly decrease the bracket-enamel shear bond strength. Furthermore, there was no significant strength loss for all groups in water-aging from 15 min to 90 days. The concentrations of DMAHDM applied in this study were consistent with previous studies that added DMAHDM in dentin bond adhesives and resin composites 27, 41) . In the present study, the orthodontic cement containing DMAHDM provided adequate bond strengths, ranging from 12.9 to 15.0 MPa, which was comparable to that of the commercial control. Therefore, the new antibacterial orthodontic cement with 3% DMAHDM appeared to yield adequate bond strength to enamel, which was durable over time, similar to that without DMAHDM.
The ideal orthodontic cement should be able to prevent white spot lesions, provide adequate bond strength to enamel surface and last for a long duration (average of 1.5-2 years). Since QAM could covalently copolymerize with the resin matrix, the antibacterial agent is immobilized in the resin and can maintain a potent and long-term antibacterial capability. A previous study investigated a QAM-containing dental adhesive and showed adequate shear bond strength and anti-biofilm capability that did not decrease after 6 months of water-ageing, compared to that at 1 day 30) . The present study showed for the first time that the shear bond strength of DMAHDM-Transbond lasted over 90 days of water-aging. However, enamel bond strength under in-vitro conditions cannot completely predict clinical efficiency, and further study is needed to evaluate the long-term mechanical strength of the orthodontic cement containing DMAHDM during immersion in saliva intraorally. Further study is also needed to investigate the effects of DMAHDM incorporation into Transbond on enamel white spot lesion reduction in vivo in a clinically relevant manner.
Further study is also needed to investigate any side-effects in applying QAMs to orthodontic cement. One issue is that QAMs are not tasteless, and tooth paste containing QAMs showed bitter and unpleasant taste in some family of QAMs. This issue may be minimized because the orthodontic cement is cured and the QAM is polymerized and immobilized in the resin. Another issue is potential irritation of QAMs to mucosal tissues. A recent study on in vitro cytotoxicity against fibroblasts and odontoblastic cells showed that the new antibacterial monomers had cytotoxicity matching HEMA and TEGDMA, with less cytotoxicity than Bis-GMA 27) . Further in vivo studies using animal models are needed to investigate the biocompatibility of orthodontic cement containing QAMs.
CONCLUSION
White spot lesions due to enamel demineralization are the most undesired adverse effect of fixed orthodontic treatments. In this study, a novel antibacterial monomer DMAHDM was incorporated into Transbond orthodontic cement for the first time. The orthodontic bracket cement incorporating 3% of DMAHDM possessed strong antibacterial effects, greatly reducing the biofilm metabolic activity and lactic acid production, and decreasing the biofilm CFU by two orders of magnitude, compared to commercial control. The modified orthodontic cement caused no loss in enamel shear bond strength, even after 90 days of water-aging. Hence, the DMAHDM-Transbond orthodontic cement is highly promising for durable enamel bonding to inhibit or eliminate white spot lesions for orthodontic patients.
